Results 191 to 200 of about 129,296 (209)

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas

Nature Biotechnology, 2020
Reuben Moncada, Dalia Barkley, Florian Wagner   +2 more
exaly  

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Nature Reviews Cancer, 2022
Mathilde Matthea Machteld Almekinders, Charlotta Mulder, Deborah Collyar   +2 more
exaly  

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

Nature Reviews Clinical Oncology, 2020
Won Jin Ho, Elizabeth M Jaffee, Lei Zheng   +2 more
exaly  

Translational advances in pancreatic ductal adenocarcinoma therapy

Nature Cancer, 2022
Abdel Hosein, Stephanie K Dougan, Andrew J Aguirre   +2 more
exaly  

Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)

Ca-A Cancer Journal for Clinicians, 2002
Monica Morrow
exaly  

Challenges in ductal carcinoma in situ risk communication and decision‐making

Ca-A Cancer Journal for Clinicians, 2012
Ann H Partridge
exaly  

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Signal Transduction and Targeted Therapy, 2020
Xunbin Wei, Shengyu Yang, Jihui Hao
exaly  

Cancer statistics: Breast cancer in situ

Ca-A Cancer Journal for Clinicians, 2015
Otis W Brawley
exaly  

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Nature Reviews Cancer, 2010
Sam C Wang, Matthias Hebrok
exaly